SCHEMBL4796199

SCHEMBL4796199

Cc1ccc(C)c(Cc2c(C)nc3c(C(=O)NCC4CCCO4)cnn3c2C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 11/20 0.64
KDM4E B2RXH2 10/20 0.64
ALDH1A1 P00352 9/20 0.64
MAPT P10636 7/20 0.64
NPSR1 Q6W5P4 7/20 0.64
HSD17B10 Q99714 7/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
LMNA P02545 6/20 0.52
KMT2A Q03164 3/20 0.52
TSHR P16473 7/20 0.51
TP53 P04637 6/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 5/20 0.51
CASP1 P29466 3/20 0.51
CASP7 P55210 3/20 0.51
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
USP2 O75604 2/20 0.49
CYP1A2 P05177 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4779873 0.90 KDM4E (0.64) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4940751 0.89 HSD17B10 (0.60) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4940985 0.88 ALDH1A1 (0.64) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4778232 0.86 TP53 (0.61) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4725736 0.85 LMNA (0.62) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4795515 0.85 KDM4E (0.65) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4780930 0.84 LMNA (0.64) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4939020 0.83 ALDH1A1 (0.62) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4725441 0.83 KDM4E (0.62) HPGDKDM4EALDH1A1MAPTNPSR1
SCHEMBL4777718 0.83 ALDH1A1 (0.54) HPGDKDM4EALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US claimed
WO-2008003753-A1 PYRAZOLO [1,5-A] PYRIMIDINE ANALOGS FOR USE AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) ACTIVITY BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO claimed
US-20080221129-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-09-11 US disclosed
WO-2008003753-A1 PYRAZOLO [1,5-A] PYRIMIDINE ANALOGS FOR USE AS INHIBITORS OF STEAROYL-COA DESATURASE (SCD) ACTIVITY BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221129-A1 New compounds SCD, SCD5, FASN HPGD 279/4885KDM4E 3813/4885ALDH1A1 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.